{
    "root": "35856ac2-298b-33c1-e063-6294a90a38bd",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "Losartan Potassium",
    "value": "20250519",
    "ingredients": [
        {
            "name": "CELLULOSE, MICROCRYSTALLINE",
            "code": "OP1R32D61U"
        },
        {
            "name": "D&C YELLOW NO. 10",
            "code": "35SW5USQ3G"
        },
        {
            "name": "FD&C BLUE NO. 2",
            "code": "L06K8R7DQK"
        },
        {
            "name": "HYPROMELLOSE 2910 (15 MPA.S)",
            "code": "36SFW2JZ0W",
            "drugbank_id": "https://go.drugbank.com/drugs/DB11075"
        },
        {
            "name": "LACTOSE MONOHYDRATE",
            "code": "EWQ57Q8I5X",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_17716"
        },
        {
            "name": "MAGNESIUM STEARATE",
            "code": "70097M6I30",
            "drugbank_id": "https://go.drugbank.com/drugs/DB14077"
        },
        {
            "name": "POLYETHYLENE GLYCOL 6000",
            "code": "30IQX730WE",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_13643"
        },
        {
            "name": "SODIUM STARCH GLYCOLATE TYPE A POTATO",
            "code": "5856J3G2A2",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_28017"
        },
        {
            "name": "STARCH, CORN",
            "code": "O8232NY3SJ",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_28017"
        },
        {
            "name": "TITANIUM DIOXIDE",
            "code": "15FIX9V2JP",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_32234"
        },
        {
            "name": "LOSARTAN POTASSIUM",
            "code": "3ST302B24A",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_6541"
        }
    ],
    "indications": {
        "text": "losartan potassium tablets angiotensin ii receptor blocker ( arb ) indicated : treatment hypertension , lower blood pressure adults children greater 6 years old . lowering blood pressure reduces risk fatal nonfatal cardiovascular events , primarily strokes myocardial infarctions . ( 1.1 ) reduction risk stroke patients hypertension left ventricular hypertrophy . evidence benefit apply black patients . ( 1.2 ) treatment diabetic nephropathy elevated serum creatinine proteinuria patients type 2 diabetes history hypertension . ( 1.3 )",
        "doid_entities": [
            {
                "text": "hypertension (DOID:10763)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_10763"
            },
            {
                "text": "stroke (DOID:6713)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_6713"
            },
            {
                "text": "nephropathy (DOID:557)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_557"
            },
            {
                "text": "proteinuria (DOID:576)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_576"
            },
            {
                "text": "type 2 diabetes (DOID:9352)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_9352"
            },
            {
                "text": "diabetes (DOID:9351)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_9351"
            }
        ],
        "orphanet_entities": []
    },
    "contraindications": {
        "text": "hypertension usual adult dose : 50 mg daily . ( 2.1 ) usual pediatric starting dose : 0.7 mg per kg daily ( 50 mg ) . ( 2.1 ) hypertensive patients left ventricular hypertrophy usual starting dose : 50 mg daily . ( 2.2 ) add hydrochlorothiazide 12.5 mg and/or increase losartan potassium 100 mg followed increase hydrochlorothiazide 25 mg blood pressure response needed . ( 2.2 , 14.2 ) nephropathy type 2 diabetic patients usual dose : 50 mg daily . ( 2.3 ) increase dose 100 mg daily blood pressure response needed . ( 2.3 )",
        "doid_entities": [
            {
                "text": "hypertension (DOID:10763)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_10763"
            },
            {
                "text": "nephropathy (DOID:557)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_557"
            }
        ],
        "orphanet_entities": []
    },
    "warningsAndPrecautions": "losartan potassium tablets , usp 25 mg : green light green , oval shaped , biconvex , film coated tablets code `` 144 `` debossed one side `` u `` side . bottles 30 : ndc 72162-2506-03 bottles 90 : ndc 72162-2506-09 bottles 1000 : ndc 72162-2506-00 storage store 20\u00b0 25\u00b0c ( 68\u00b0 77\u00b0f ) [ usp controlled room temperature ] . keep container tightly closed . protect light . repackaged/relabeled : bryant ranch prepack , inc. burbank , ca 91504",
    "adverseReactions": "hypersensitivity component . ( 4 ) coadministration aliskiren patients diabetes . ( 4 )",
    "indications_original": "Losartan potassium tablets are angiotensin II receptor blocker (ARB) indicated for: Treatment of hypertension, to lower blood pressure in adults and children greater than 6 years old. Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. ( 1.1 ) Reduction of the risk of stroke in patients with hypertension and left ventricular hypertrophy. There is evidence that this benefit does not apply to Black patients. ( 1.2 ) Treatment of diabetic nephropathy with an elevated serum creatinine and proteinuria in patients with type 2 diabetes and a history of hypertension. ( 1.3 )",
    "contraindications_original": "Hypertension Usual adult dose: 50 mg once daily. ( 2.1 ) Usual pediatric starting dose: 0.7 mg per kg once daily (up to 50 mg). ( 2.1 ) Hypertensive Patients with Left Ventricular Hypertrophy Usual starting dose: 50 mg once daily. ( 2.2 ) Add hydrochlorothiazide 12.5 mg and/or increase losartan Potassium to 100 mg followed by an increase to hydrochlorothiazide 25 mg if further blood pressure response is needed. ( 2.2 , 14.2 ) Nephropathy in Type 2 Diabetic Patients Usual dose: 50 mg once daily. ( 2.3 ) Increase dose to 100 mg once daily if further blood pressure response is needed. ( 2.3 )",
    "warningsAndPrecautions_original": "Losartan potassium tablets, USP 25 mg:\n                  \n                  \n                     Green to light green, oval shaped, biconvex, film coated tablets with code \"144\" debossed on one side and \"U\" on other side.\n                  \n                  \n                  \n                     Bottles of 30: NDC 72162-2506-03\n                  \n                  \n                     Bottles of 90: NDC 72162-2506-09\n                  \n                  \n                     Bottles of 1000: NDC 72162-2506-00\n                  \n                  \n                  \n                  \n                     Storage\n                  \n                  \n                     Store at 20\u00b0 to 25\u00b0C (68\u00b0 to 77\u00b0F) [see USP Controlled Room Temperature].\n                  \n                  \n                     Keep container tightly closed. Protect from light.\n                  \n                  \n                  \n                     Repackaged/Relabeled by:\n   \nBryant Ranch Prepack, Inc.\n   \nBurbank, CA 91504",
    "adverseReactions_original": "Hypersensitivity to any component. ( 4 ) Coadministration with aliskiren in patients with diabetes. ( 4 )",
    "drug": [
        {
            "name": "Losartan Potassium",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_6541"
        }
    ]
}